Cargando…
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
In 2020, despite challenges related to the COVID-19 pandemic, the US FDA approved 30 new drugs and biologic agents, 45 supplemental drug and biologic applications and 1 biosimilar application in oncology.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844812/ https://www.ncbi.nlm.nih.gov/pubmed/33514911 http://dx.doi.org/10.1038/s41571-021-00477-1 |